Role of Cotinine in Nicotine Use Disorders
Role of Cotinine in Nicotine Use Disorders
批准号:
10194435
负责人:
Zheng-Ming Ding
金额:
$35.62万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2023-06-30
关键词:
AddressAttentionBehaviorBehavioralBloodBrainBupropionCessation of lifeCotinineCuesDataDeveloped CountriesDevelopmentDopamineDoseEffectivenessFDA approvedFemaleFutureGoalsHalf-LifeIndividualIntravenousKnowledgeLightMaintenanceMecamylamineMediatingModelingMolecular TargetNeurosciencesNicotineNicotine DependenceNicotine Use DisorderNicotinic ReceptorsPharmaceutical PreparationsPharmacologyPilot ProjectsPlasmaPlayProceduresPropertyPsychological reinforcementRattusRelapseReportingResearchRewardsRoleSelf AdministrationSex DifferencesStressTargeted Researchcigarette smokingcravingdrug of abuseefficacious treatmentextracellularinsightinterdisciplinary approachmalemesolimbic systemneurochemistrynew therapeutic targetnicotine abusenicotine seeking behaviornicotine usenovelnovel therapeuticsprematuresmoking cessationtherapeutic targetvarenicline
中文摘要
摘要/描述
本项目的主要目的是了解可替宁(COT)的奖励相关作用,
尼古丁的主要代谢物(NIC),及其在NIC使用障碍的发展中的潜在作用。很长的-
长期目标是更好地理解NIC强化中COT相关机制,并提供
针对COT作用的研究的基本原理,用于未来开发辅助吸烟的新疗法
停止总体假设是COT在NIC滥用的发展中起着重要作用
和成瘾通过一系列机制,包括其自身的强化和渴望-/复发-
如影响,在这些影响中涉及的独特机制,它与NIC的相互作用,以促进
增强和渴望-/复发样的效果。一种多学科的方法,包括行为
神经科学和神经化学将在这个项目中使用。因此,目标1将决定
与NIC相比,COT的奖励相关行为和神经化学作用。aim 2将
确定参与强化效应的机制的潜在相似性或差异
COT与NIC。目标3将研究COT和NIC在促进
加固.目标4将研究COT的渴望/复发样特性及其对人的影响。
与NIC的相互作用,以促进渴望/复发样作用使用恢复模型。潜在
COT行动中的性别差异也将被研究。这是一个非常新颖的项目。信息
这不仅将大大增加我们对COT相关机制的理解,
NIC的强化和NIC使用障碍的发展,也凸显了
将COT作为治疗NIC使用障碍的新策略。
英文摘要
ABSTRACT/DESCRIPTION
The major objective of the current project is to understand the reward-related actions of cotinine (COT),
the major metabolite of nicotine (NIC), and its potential role in the development of NIC use disorder. The long-
term goal is to provide a better understanding of COT-related mechanisms in NIC reinforcement and provide
rationale for research targeting the actions of COT for future development of new therapies for aiding smoking
cessation. The overarching hypothesis is that COT plays an important role in the development of NIC abuse
and addiction through a combination of mechanisms, including its own reinforcing and craving-/relapse-
like effects, unique mechanisms involved in these effects, its interactions with NIC to promote
reinforcing and craving-/relapse-like effects. A multidisciplinary approach encompassing behavioral
neuroscience and neurochemistry will be employed in this project. Thus, Aim 1 will determine the
reward-related behavioral and neurochemical effects of COT as compared to NIC. Aim2 will
determine potential similarities or differences in mechanisms involved in the reinforcing effects of
COT vs NIC. Aim 3 will examine potential interactions between COT and NIC in promote
reinforcement. And Aim 4 will investigate the craving-/relapse-like properties of COT and its
interactions with NIC to promote craving-/relapse-like effects using reinstatement models. Potential
sex differences in COT's actions will also be examined. This is a highly novel project. Information
attained will not only significantly increase our understanding of COT-related mechanisms underlying
NIC reinforcement and the development of NIC use disorders, but also highlight the importance of
targeting COT as a new strategy for treating NIC use disorders.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The involvement of dopamine and D2 receptor-mediated transmission in effects of cotinine in male rats.
多巴胺和 D2 受体介导的传递参与可替宁对雄性大鼠的影响。
DOI:
10.1016/j.neuropharm.2023.109495
发表时间:
2023
期刊:
Neuropharmacology
影响因子:
4.7
作者:
[Tan,Xiaoying, Neslund,ElizabethM, Ding,Zheng-Ming]
通讯作者:
Ding,Zheng-Ming
Methoxsalen inhibited the acquisition of nicotine self-administration: attenuation by cotinine replacement in rats.
甲氧沙林抑制自我给药尼古丁的获得:大鼠体内通过可替宁替代而减弱。
DOI:
10.1101/2023.06.04.543614
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Ding,Zheng-Ming, Neslund,ElizabethM, Sun,Dongxiao, Tan,Xiaoying]
通讯作者:
Tan,Xiaoying
DOI:
10.1097/fbp.0000000000000696
发表时间:
2022-10-01
期刊:
BEHAVIOURAL PHARMACOLOGY
影响因子:
1.6
作者:
[Tan, Xiaoying, Neslund, Elizabeth, Ding, Zheng-Ming]
通讯作者:
Ding, Zheng-Ming
DOI:
10.3389/fnbeh.2021.758252
发表时间:
2021
期刊:
Frontiers in behavioral neuroscience
影响因子:
3
作者:
[Tan X, Vrana K, Ding ZM]
通讯作者:
Ding ZM
DOI:
10.1016/j.bbr.2021.113596
发表时间:
2022-01-24
期刊:
Behavioural brain research
影响因子:
2.7
作者:
[Tan X, Ingraham CM, McBride WJ, Ding ZM]
通讯作者:
Ding ZM
Role of Cotinine in Nicotine Use Disorders
-
批准号:10120071
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2017
-
负责人:Zheng-Ming Ding
-
依托单位:
Role of Cotinine in Nicotine Use Disorders
-
批准号:9743125
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2017
-
负责人:Zheng-Ming Ding
-
依托单位:
Role of Cotinine in Nicotine Use Disorders
-
批准号:9362587
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2017
-
负责人:Zheng-Ming Ding
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: